Virtual Pharmacy Education 2020 Speakers

Virtual Pharmacy Education 2020 - AACP Annual Meeting - July 13-31, 2020

Opening General Session

A Lawyer’s Prescription for Pharmacists’ Role in Achieving Health Equity

Monday, July 13, 1:00 p.m.-2:30 p.m. ET
Live online Q&A with Dayna Bowen Matthew 

Racial, ethnic and socioeconomic health disparities in the United States are well documented but the causes are still poorly understood. Dayna Bowen Matthew will identify some causes that are uniquely within reach of pharmacists to address. Pharmacists and their educators can defeat unjust and avoidable health disparities as they are often the most accessible and trusted healthcare professional available to underserved patient populations. Moreover, pharmacists are often intimately familiar with the neighborhood, environmental and family contexts in which patients live, work and play. As educators who train the pharmacy professionals and who are proximate to vulnerable patient populations, faculty are uniquely positioned to reduce and even eradicate disparities in vaccine coverage, substance dependency, diabetes, asthma and more. The presentation will identify biases that stand in the way of solutions that could dramatically reduce health disparities in America, and conclude by suggesting that the members of AACP hold the key to the prescription for health equity.

Dayna Matthew, J.D., Ph.D.

William L. Matheson and Robert M. Morgenthau Distinguished Professor of Law
F. Palmer Weber Research Professor of Civil Liberties and Human Rights
Professor of Public Health Sciences
Director, The Equity Center
University of Virginia

Dr. Matthew is the William L. Matheson and Robert M. Morgenthau Distinguished Professor of Law and the F. Palmer Weber Research Professor of Civil Liberties and Human Rights at the University of Virginia School of Law. She holds an appointment in the School of Medicine’s Department of Public Health Sciences. Dr. Matthew is a non-resident senior scholar at the Brookings Institution, in the Economic Studies Department. She has worked as a senior advisor for the Environmental Protection Agency Office of Civil Rights, as a Robert Wood Johnson Health Policy Fellow, and on Capitol Hill, helping to address public health disparities for disadvantaged communities. Dr. Matthew cofounded the Colorado Health Equity Project, a medical-legal partnership incubator; the Equity Institute Initiative, a community-engaged scholarship partnership; and she is the author of Just Medicine: A Cure for Racial Inequality in American Health Care.

Friday General Session

Driving Chronic Medication Management (CMM) Implementation: 10-Year Journey of Diffusion and Its Implications to Pharmacy Education and Training

Friday, July 17, 1:00 p.m.-2:00 p.m. ET 
Live Broadcast

Demand for clinical pharmacists in the U.S. Department of Veterans Affairs (VA) has risen sharply and continues its upward trajectory. During this session, Dr. Morreale will share the advances in clinical pharmacy practice that have been seen in the past 10 years by the largest managed care provider in the U.S.: the VA. The VA’s approach to expanding clinical pharmacy programs through centralized processes involving gap analysis, standardization of practices, mentoring, consultative visits and education has been innovative and largely successful. Dr. Morreale will discuss the lessons learned from the VA focus of developing and expanding clinical pharmacy practices throughout the country and the implications for the future of pharmacy education and residencies. 

Anthony P. Morreale, Pharm.D. MBA, BCPS, FASHP

Associate Chief Consultant for Clinical Pharmacy and Policy
Central Office, Department of Veterans Affairs Pharmacy Benefits Management

Dr. Morreale currently serves as the associate chief consultant for clinical pharmacy and policy for the Department of Veterans Affairs Pharmacy Benefits Management in VA Central Office. He has led multiple initiatives focused on organizing, standardizing and expanding the scope of clinical pharmacy practice throughout the VA. His accomplishments include creating the first VA pharmacoeconomics and pharmacogenomics pharmacist positions; serving as a founding member of VA’s national formulary and PBM outcomes research group; establishing the first accredited oncology, pharmacoeconomics, pharmacogenomics, nephrology and clinical informatics residency programs in VA; and establishing the national VA PBM Clinical Pharmacy Practice Office. Dr. Morreale is board certified in pharmacotherapy and has been the recipient of numerous professional recognitions and awards including being recognized as a fellow of the American and California Society of Health Systems Pharmacists for his many contributions to the profession. He has also been recognized as an honorary member of the United States Public Health Service for his dedication to public health initiatives. 

Science Plenary

The New Science of Wellness and What it Means for 21st Century Medicine

Monday, July 20, Noon-1:00 p.m. ET
Live online Q&A with Nathan Price

Healthcare is becoming more proactive and data-rich, with increasing focus on maintaining and enhancing wellness beyond just reacting to disease. The Institute of Systems Biology has assembled a data set of thousands of people who participated in a “scientific wellness” program integrating genomics, proteomics, metabolomics, microbiomes, clinical chemistries and wearable devices coupled with health coaching for behavior change. The resulting personal, dense, dynamic data (PD3) clouds (Price et al., Nature Biotechnology, 2017) provide a powerful platform for scientific discovery, where deep longitudinal data enables detection of the earliest transition states between wellness and disease. 
Dr. Price will discuss how the interpretation of these data led to actionable findings for individuals to improve health, reduce risk drivers of disease, understand how genetic risk manifests in the body throughout life (e.g., in Alzheimer’s disease) and show individual trajectories into disease (e.g., cancers). In addition, Dr. Price will describe what the data shows about healthy aging, how insights into human biology (e.g., microbiome-human metabolome connections, Wilmanski et al., Nature Biotechnology, 2019) can be drawn from the data and conclude with a big picture view of how this endeavor relates to the future of healthcare. 

Nathan Price, Ph.D.

Professor and Associate Director, Institute for Systems Biology
Affiliate Faculty, Department of Bioengineering, Computer Science & Engineering; and Department of Molecular & Cellular Biology, University of Washington 

Dr. Price is professor and associate director of the Institute for Systems Biology in Seattle, where he co-directs the Hood-Price Integrated Lab for Systems Biomedicine with Lee Hood. He is also affiliate faculty at the University of Washington in the Departments of Bioengineering, Computer Science & Engineering, and Molecular & Cellular Biology. In 2019, Dr. Price was selected by the National Academy of Medicine as one of their “10 Emerging Leaders in Health and Medicine.” He was a co-founder and on the board of directors for Arivale, which brought an innovative “scientific wellness” approach to consumers from 2015-2019, and was named as Geekwire’s 2016 startup of the year. He was the recipient of early career awards from the National Institutes of Health, the National Science Foundation, American Cancer Society, the Roy J. Carver Charitable Trust, and Genome Technology. He was also named a Camille Dreyfus Teacher-Scholar and received the 2016 Grace A. Goldsmith Award for his work in pioneering “scientific wellness.” He serves on numerous advisory boards including for Roche (Personalized Medicine Division), Providence St. Joseph Health, Habit, Trelys, Novo Nordisk Foundation Center for Biosustainability, Science Translational Medicine and Cell Systems.